UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Cor et vasa (English ed.), 2023-05, Vol.65 (2), p.350-434

2023

Volltextzugriff (PDF)

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

European heart journal, 2021-04, Vol.42 (16), p.1554-1568

2021

Volltextzugriff (PDF)

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

European journal of heart failure, 2021-04, Vol.23 (4), p.512-526

2021

Volltextzugriff (PDF)

Fabry disease revisited: Management and treatment recommendations for adult patients

Molecular genetics and metabolism, 2018-04, Vol.123 (4), p.416-427

2018

Volltextzugriff (PDF)

Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week

Journal of the American College of Cardiology, 2021-02, Vol.77 (7), p.922-936

2021

Volltextzugriff (PDF)

Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism

Experimental and clinical cardiology, 2013-01, Vol.18 (2), p.129-138

2013

Volltextzugriff (PDF)

Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial

Critical care (London, England), 2022-10, Vol.26 (1), p.1-330, Article 330

2022

Volltextzugriff (PDF)

Personalised exercise prescription: Finding the best for our patients

European journal of preventive cardiology, 2020-09, Vol.27 (13), p.1366-1368

2020

Volltextzugriff (PDF)

Polypill Strategy in Secondary Cardiovascular Prevention

The New England journal of medicine, 2022-09, Vol.387 (11), p.967-977

2022

Volltextzugriff (PDF)

An expert consensus document on the management of cardiovascular manifestations of Fabry disease

European journal of heart failure, 2020-07, Vol.22 (7), p.1076-1096

2020

Volltextzugriff (PDF)

Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease

Frontiers in genetics, 2024, Vol.15, p.1395287-1395287

2024

Volltextzugriff (PDF)

30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 - 2016/17

PloS one, 2020-05, Vol.15 (5), p.e0232845-e0232845

2020

Volltextzugriff (PDF)

A unique case of extensive myocardial late iodine enhancement on CT in Anderson-Fabry disease

European heart journal cardiovascular imaging, 2023-03, Vol.24 (4), p.e63-e63

2023

Volltextzugriff (PDF)

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

Orphanet journal of rare diseases, 2023-10, Vol.18 (1), p.1-332, Article 332

2023

Volltextzugriff (PDF)

The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts

Molecular genetics and metabolism reports, 2019-06, Vol.19, p.100454-100454, Article 100454

2019

Volltextzugriff (PDF)

The heart in Anderson-Fabry disease and other lysosomal storage disorders

Heart (British Cardiac Society), 2007-04, Vol.93 (4), p.528-535

2007

Volltextzugriff (PDF)

Variations of the Saphenopopliteal Junction: An Ultrasonography Study in a Young Population, A Systematic Review and A Meta-Analysis

Angiology, 2024-07, Vol.75 (6), p.527-535

2024

Volltextzugriff (PDF)

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

PloS one, 2021-01, Vol.16 (1), p.e0245752-e0245752

2021

Volltextzugriff (PDF)

Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis

BioMed research international, 2016-01, Vol.2016, p.2829583-6

2016

Volltextzugriff (PDF)

European expert consensus statement on therapeutic goals in Fabry disease

Molecular genetics and metabolism, 2018-07, Vol.124 (3), p.189-203

2018

Volltextzugriff (PDF)

Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy

The American journal of cardiology, 2021-07, Vol.150, p.110-113

2021

Volltextzugriff (PDF)

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis

European heart journal cardiovascular imaging, 2023-11, Vol.24 (12), p.1629-1637

2023

Volltextzugriff (PDF)

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Journal of medical genetics, 2016-07, Vol.53 (7), p.495-502

2016

Volltextzugriff (PDF)

1 – 25 von 442

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(430)
Mit Volltextzugriff
(409)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(275)
Life Sciences & Biomedicine
(267)
Humans
(208)
Cardiovascular System & Cardiology
(162)
Cardiac & Cardiovascular Systems
(145)
Male
(134)
Female
(123)
Middle Aged
(99)
Adult
(69)
Aged
(68)
Fabry Disease
(45)
Echocardiography
(43)
Patients
(39)
Risk Factors
(39)
Heart Failure
(37)
Treatment Outcome
(36)
General & Internal Medicine
(34)
Cardiomyopathy
(33)
Cardiology
(32)
Cardiovascular
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

Fabry disease revisited: Management and treatment recommendations for adult patients

Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week

Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases

Extracorporeal versus conventional cardiopulmonary resuscitation for refractory out-of-hospital cardiac arrest: a secondary analysis of the Prague OHCA trial

Personalised exercise prescription: Finding the best for our patients

Polypill Strategy in Secondary Cardiovascular Prevention

An expert consensus document on the management of cardiovascular manifestations of Fabry disease

Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of Fabry disease

30-year trends in major cardiovascular risk factors in the Czech population, Czech MONICA and Czech post-MONICA, 1985 - 2016/17

A unique case of extensive myocardial late iodine enhancement on CT in Anderson-Fabry disease

Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts

The heart in Anderson-Fabry disease and other lysosomal storage disorders

Variations of the Saphenopopliteal Junction: An Ultrasonography Study in a Young Population, A Systematic Review and A Meta-Analysis

The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension

Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis

European expert consensus statement on therapeutic goals in Fabry disease

Usefulness of Alcohol Septal Ablation in the Left Ventricular Outflow Tract Obstruction in Fabry Disease Cardiomyopathy

Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Suchergebnisse filtern